Page last updated: 2024-09-03

imatinib mesylate and African Lymphoma

imatinib mesylate has been researched along with African Lymphoma in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Acquaviva, J; Chen, X; Ren, R	1
Ascani, S; Bonomini, S; Caramatti, C; Colla, S; Craviotto, L; Crugnola, M; De Celis, I; Giuliani, N; Hojden, M; Morandi, F; Rizzoli, V; Sabbatini, E; Sammarelli, G	1
Buchdunger, E; Fabbro, D; Hallek, M; Hu, Y; Li, S; Liu, Y; Pelletier, S; Van Etten, RA; Warmuth, M	1
Asano, S; Bai, Y; Chen, M; Harata, M; Iseki, T; Izawa, K; Kobayashi, S; Maruyama, K; Nagamura, F; Nakazawa, S; Ooi, J; Soda, Y; Sugita, K; Takahashi, S; Takahashi, TA; Takizawa, T; Tani, K; Tojo, A; Tomonari, A; Tsuji, T; Uchimaru, K	1
Arthur, D; Choksi, M; Dunbar, C; Klion, A; Noel, P; Nutman, T; O'neal, P; Robyn, J; Wlodarska, I	1
Duffy, TM; Hu, Y; Lee, FY; Li, S; Swerdlow, S; Weinmann, R	1
Dorshkind, K; Witte, ON	1

Reviews

1 review(s) available for imatinib mesylate and African Lymphoma

Article	Year
Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia. European journal of haematology, 2004, Volume: 72, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction	2004

Article

Year

Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.

European journal of haematology, 2004, Volume: 72, Issue:5

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Blast Crisis; Burkitt Lymphoma; Cytarabine; Daunorubicin; Female; Humans; Imatinib Mesylate; Immunophenotyping; Karyotyping; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Megakaryoblastic, Acute; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Piperazines; Pyrimidines; Remission Induction

2004

Other Studies

6 other study(ies) available for imatinib mesylate and African Lymphoma

Article	Year
IRF-4 functions as a tumor suppressor in early B-cell development. Blood, 2008, Nov-01, Volume: 112, Issue:9 Topics: Animals; B-Lymphocytes; Base Sequence; Benzamides; Bone Marrow Transplantation; Burkitt Lymphoma; Cell Differentiation; Cell Line; Cyclin-Dependent Kinase Inhibitor Proteins; DNA Primers; Fusion Proteins, bcr-abl; Genes, abl; Imatinib Mesylate; Interferon Regulatory Factors; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Transformation, Genetic; Tumor Suppressor Proteins	2008
Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia. Nature genetics, 2004, Volume: 36, Issue:5 Topics: Animals; Benzamides; Burkitt Lymphoma; Cell Division; Drug Therapy, Combination; Enzyme Activation; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Piperazines; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-hck; Pyrimidines; Pyrroles; src-Family Kinases	2004
CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells. Blood, 2004, Sep-01, Volume: 104, Issue:5 Topics: Antigens, CD19; Antigens, CD34; Antineoplastic Agents; Benzamides; Burkitt Lymphoma; Cell Death; Humans; Imatinib Mesylate; In Vitro Techniques; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Liposomes; Philadelphia Chromosome; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Tumor Cells, Cultured	2004
Imatinib-responsive hypereosinophilia in a patient with B cell ALL. Leukemia & lymphoma, 2004, Volume: 45, Issue:12 Topics: Adult; Benzamides; Burkitt Lymphoma; Eosinophils; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukocyte Count; Male; Piperazines; Pyrimidines	2004
Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proceedings of the National Academy of Sciences of the United States of America, 2006, Nov-07, Volume: 103, Issue:45 Topics: Animals; Antineoplastic Agents; B-Lymphocytes; Benzamides; Blast Crisis; Burkitt Lymphoma; Cell Line, Tumor; Cell Transformation, Neoplastic; Dasatinib; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplastic Stem Cells; Piperazines; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Thiazoles	2006
Linking the hematopoietic microenvironment to imatinib-resistant Ph+ B-ALL. Genes & development, 2007, Sep-15, Volume: 21, Issue:18 Topics: Animals; Antineoplastic Agents; Benzamides; Burkitt Lymphoma; Disease Progression; Drug Resistance, Neoplasm; Hematopoietic Stem Cells; Humans; Imatinib Mesylate; Mice; Models, Biological; Neoplastic Stem Cells; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines	2007